KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Payables (2016 - 2025)

Idexx Laboratories (IDXX) has 17 years of Payables data on record, last reported at $110.4 million in Q4 2025.

  • For Q4 2025, Payables fell 3.33% year-over-year to $110.4 million; the TTM value through Dec 2025 reached $110.4 million, down 3.33%, while the annual FY2025 figure was $110.4 million, 3.33% down from the prior year.
  • Payables reached $110.4 million in Q4 2025 per IDXX's latest filing, down from $122.3 million in the prior quarter.
  • Across five years, Payables topped out at $127.3 million in Q2 2022 and bottomed at $86.7 million in Q3 2021.
  • Average Payables over 5 years is $111.5 million, with a median of $113.4 million recorded in 2023.
  • Peak YoY movement for Payables: soared 55.77% in 2021, then fell 15.4% in 2023.
  • A 5-year view of Payables shows it stood at $116.1 million in 2021, then decreased by 5.1% to $110.2 million in 2022, then increased by 0.38% to $110.6 million in 2023, then rose by 3.22% to $114.2 million in 2024, then fell by 3.33% to $110.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Payables were $110.4 million in Q4 2025, $122.3 million in Q3 2025, and $116.6 million in Q2 2025.